![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » Medtronic Gets FDA Approval for Two Drug-Eluting Stents
Medtronic Gets FDA Approval for Two Drug-Eluting Stents
Medtronic has received FDA’s approval for its Onyx Frontier and Resolute Onyx drug-eluting stents that use a single-wire design.
The devices have been approved to treat non-left main bifurcation lesions that occur when plaque builds up around the junction of two coronary arteries.
The open-cell stents allow for easier side branch access while maintaining a consistent stent scaffolding.
Based on the new indication, Medtronic plans to provide a “robust portfolio of medical education and procedural training for physicians” for treating bifurcation lesions, the company said.
Both devices previously earned CE mark certifications.
Upcoming Events
-
11Jul
-
18Jul
-
21Oct